• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏球体收缩性和钙释放的测量

Measurement of Contractility and Calcium Release in Cardiac Spheroids.

作者信息

Zuppinger Christian

机构信息

Cardiology Department, DBMR MEM C812, University Hospital Bern, Bern, Switzerland.

出版信息

Methods Mol Biol. 2019;1929:41-52. doi: 10.1007/978-1-4939-9030-6_4.

DOI:10.1007/978-1-4939-9030-6_4
PMID:30710266
Abstract

There is a need for organotypic in vitro models that resemble the native tissue in functionality and tissue architecture for disease models and drug development. To this end, many 3D culture formats have been developed over time. Among the most often used type is the scaffold-free multicellular aggregate, also called spheroid, that forms by self-assembly. However, working with 3D cultures can be challenging because single cells are not as accessible as in 2D cultures and standard lab procedures must be adapted or replaced altogether. This chapter describes methods to create cardiac spheroids consisting of human iPSC-derived cardiomyocytes and cardiac fibroblasts and how to measure contractility or calcium signals using quantitative video analysis and confocal microscopy. Emphasis is on the particular challenges that 3D cultures pose and on affordable methods that do not require specialized equipment.

摘要

对于疾病模型和药物开发而言,需要在功能和组织结构上类似于天然组织的器官型体外模型。为此,随着时间的推移,已经开发出许多三维培养形式。最常用的类型之一是无支架多细胞聚集体,也称为球体,它通过自组装形成。然而,使用三维培养可能具有挑战性,因为单个细胞不像二维培养那样易于操作,并且标准实验室程序必须进行调整或完全替换。本章描述了创建由人诱导多能干细胞衍生的心肌细胞和心脏成纤维细胞组成的心脏球体的方法,以及如何使用定量视频分析和共聚焦显微镜测量收缩性或钙信号。重点是三维培养带来的特殊挑战以及不需要专门设备的经济实惠的方法。

相似文献

1
Measurement of Contractility and Calcium Release in Cardiac Spheroids.心脏球体收缩性和钙释放的测量
Methods Mol Biol. 2019;1929:41-52. doi: 10.1007/978-1-4939-9030-6_4.
2
Development and Characterization of a Scaffold-Free 3D Spheroid Model of Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes.诱导多能干细胞来源的人心肌细胞无支架三维球体模型的构建与表征
Tissue Eng Part C Methods. 2015 Aug;21(8):852-61. doi: 10.1089/ten.TEC.2014.0376. Epub 2015 Mar 16.
3
A Scalable Approach Reveals Functional Responses of iPSC Cardiomyocyte 3D Spheroids.一种可扩展的方法揭示了诱导多能干细胞衍生心肌细胞三维球体的功能反应。
SLAS Discov. 2021 Mar;26(3):352-363. doi: 10.1177/2472555220975332. Epub 2020 Dec 7.
4
Stem Cell-Derived Cardiac Spheroids as 3D In Vitro Models of the Human Heart Microenvironment.干细胞衍生的心脏球体作为人类心脏微环境的3D体外模型
Methods Mol Biol. 2019;2002:51-59. doi: 10.1007/7651_2018_187.
5
Spheroids of cardiomyocytes derived from human-induced pluripotent stem cells improve recovery from myocardial injury in mice.源自人诱导多能干细胞的心肌细胞球体改善了小鼠心肌损伤的恢复。
Am J Physiol Heart Circ Physiol. 2018 Aug 1;315(2):H327-H339. doi: 10.1152/ajpheart.00688.2017. Epub 2018 Apr 6.
6
Phenotypic Assays for Characterizing Compound Effects on Induced Pluripotent Stem Cell-Derived Cardiac Spheroids.用于表征化合物对诱导多能干细胞衍生的心脏球体影响的表型分析
Assay Drug Dev Technol. 2017 Aug/Sep;15(6):280-296. doi: 10.1089/adt.2017.792.
7
Phenotypic Characterization of Toxic Compound Effects on Liver Spheroids Derived from iPSC Using Confocal Imaging and Three-Dimensional Image Analysis.使用共聚焦成像和三维图像分析对源自诱导多能干细胞的肝类器官中有毒化合物作用的表型特征分析
Assay Drug Dev Technol. 2016 Sep;14(7):381-94. doi: 10.1089/adt.2016.729. Epub 2016 Aug 5.
8
Early Vascular Cells Improve Microvascularization Within 3D Cardiac Spheroids.早期血管细胞可改善 3D 心脏球体中的微血管化。
Tissue Eng Part C Methods. 2020 Feb;26(2):80-90. doi: 10.1089/ten.TEC.2019.0228.
9
3D Co-culture of hiPSC-Derived Cardiomyocytes With Cardiac Fibroblasts Improves Tissue-Like Features of Cardiac Spheroids.人诱导多能干细胞衍生的心肌细胞与心脏成纤维细胞的3D共培养改善了心脏球体的类组织特征。
Front Mol Biosci. 2020 Feb 14;7:14. doi: 10.3389/fmolb.2020.00014. eCollection 2020.
10
Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology.心脏球体作为体外生物工程心脏组织用于研究人类心脏病理生理学。
J Vis Exp. 2021 Jan 23(167). doi: 10.3791/61962.

引用本文的文献

1
Model construction and clinical therapeutic potential of engineered cardiac organoids for cardiovascular diseases.用于心血管疾病的工程化心脏类器官的模型构建及临床治疗潜力
Biomater Transl. 2024 Nov 15;5(4):337-354. doi: 10.12336/biomatertransl.2024.04.002. eCollection 2024.
2
Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease.心脏类器官:用于模拟心脏发育和疾病的 3D 技术。
Stem Cell Rev Rep. 2022 Dec;18(8):2593-2605. doi: 10.1007/s12015-022-10385-1. Epub 2022 May 8.
3
Possible Treatment of Myocardial Infarct Based on Tissue Engineering Using a Cellularized Solid Collagen Scaffold Functionalized with Arg-Glyc-Asp (RGD) Peptide.
基于 Arg-Glyc-Asp(RGD)肽功能化细胞化固体胶原支架的心肌梗死的可能治疗方法。
Int J Mol Sci. 2021 Nov 22;22(22):12563. doi: 10.3390/ijms222212563.
4
Cardiac Organoids to Model and Heal Heart Failure and Cardiomyopathies.用于模拟和治疗心力衰竭及心肌病的心脏类器官
Biomedicines. 2021 May 18;9(5):563. doi: 10.3390/biomedicines9050563.
5
Current challenges in three-dimensional bioprinting heart tissues for cardiac surgery.三维生物打印心脏组织用于心脏手术的当前挑战。
Eur J Cardiothorac Surg. 2020 Sep 1;58(3):500-510. doi: 10.1093/ejcts/ezaa093.
6
Engineering tissue-specific blood vessels.构建组织特异性血管。
Bioeng Transl Med. 2019 Jul 2;4(3):e10139. doi: 10.1002/btm2.10139. eCollection 2019 Sep.
7
3D Cardiac Cell Culture: A Critical Review of Current Technologies and Applications.3D心脏细胞培养:当前技术与应用的批判性综述
Front Cardiovasc Med. 2019 Jun 26;6:87. doi: 10.3389/fcvm.2019.00087. eCollection 2019.